Unlock instant, AI-driven research and patent intelligence for your innovation.

Polymorphic forms of dasatinib

A dasatinib form technology, applied in the field of co-crystal and solvate of dasatinib and its preparation, can solve uneconomical problems

Pending Publication Date: 2020-05-05
BIOCON LTD
View PDF20 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0031] Dasatinib-1,2-propanediol solvate formation requires 12 volumes of solvent, which is also uneconomical

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polymorphic forms of dasatinib
  • Polymorphic forms of dasatinib
  • Polymorphic forms of dasatinib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1a

[0910] Example 1a: (using DMAc and methanol as solvent) Preparation of Dasatinib-thymine co-crystal of formula Ia from II-one-pot synthesis method

[0911]

Embodiment -1b

[0912] Add Formula II (2.00g, 0.0051mol, 1.00 equivalent), Formula III (6.00mL, 3.00vol) and N, N-dimethylacetamide ( 2.00mL, 1.00vol) and heat the material to 75±2°C. Maintain the reaction mass at 75±2°C under stirring. The resulting reaction mass (containing formula I) was cooled to 25±5°C, and thymine (0.96g, 0.007mol, 1.50 equivalent) was added to the reaction mass at 25±5°C under stirring. Under stirring, methanol (60.0 mL, 30.0 vol) was added to the reaction mass at a constant rate at 25±5°C. The material is heated to 60±2°C, and the resulting suspension is maintained at the same temperature under stirring. Cool the material to 25±5°C and maintain the same temperature. Water (15 mL, 7.50 vol) was added to the reaction mass at a constant rate with stirring. Maintain the reaction mass at 25±5°C. The material was filtered, and the solid was washed with methanol (10.0 mL, 5.00 vol), sucked dry and dried under vacuum at 50±5°C to obtain the dasatinib-thymine co-crystal of...

Embodiment -1c

[0916] Add formula II (50.00g, 0.127mol, 1.00 equivalent), formula III (150mL, 3.00vol) and N, N-dimethylacetamide (50.0 vol) to a 3L glass container equipped with a stirrer, condenser and thermometer probe. mL, 1.00vol) and heat the material to 75±5°C. Maintain the reaction mass at 75±5°C under stirring. The resulting reaction mass was cooled to 25±5°C, and adenine (25.7g, 0.190mol, 1.50 equivalent) was added to the reaction mass at 25±5°C under stirring. Under stirring, methanol (1500 mL, 30.0 vol) was added to the reaction mass at a constant rate at 25±5°C. The material is heated to 60±2°C, and the resulting suspension is maintained at the same temperature under stirring. Cool the material to 25±5°C and maintain the same temperature. Water (650 mL, 13.0 vol) was added to the reaction mass at a constant rate with stirring. Maintain the reaction mass at 25±5°C. The material was filtered, and the solid was washed with methanol (350 mL, 7.00 vol), sucked dry, and dried unde...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The present invention provides for the dasatinib-thymine co-crystal and dasatinib-adenine co-crystal. The present invention further provides dasatinib-butanediol solvate. The present invention furtherprovides for crystalline dasatinib-(+-)- 1, 2-Butane diol, crystalline dasatinib (R)-1, 2-Butanediol, crystalline dasatinib (S)-1, 2-Butanediol and crystalline dasatinib (+-)-2, 3-Butanediol and processes for preparation thereof. The present invention also provides for a process for preparation of amorphous dasatinib using dasatinib-butanediol solvate. The present invention further provides for the preparation of anhydrous dasatinib. The present invention also provides for a process for preparation of dasatinib monohydrate from anhydrous dasatinib.

Description

[0001] Cross references to related applications [0002] This application requires the Indian patent application with the application number 201741024067 filed on July 7, 2017, the Indian patent application with the application number 201741029965 filed on August 24, 2017, and the application number 201841001249 filed on January 11, 2018 The priority of the Indian patent application and the Indian patent application filed on February 28, 2018 with the application number 201841007613, which is incorporated herein by reference. Technical field [0003] The present invention relates to polymorphic forms of dasatinib. In particular, the present invention relates to co-crystals and solvates of dasatinib and methods for their preparation. [0004] Background technique [0005] Star Race ( Dasatinib monohydrate) is a kinase inhibitor. The chemical name of dasatinib monohydrate is N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]- 2-Methyl-4-pyrimidinyl]amino]-thiazol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D417/12
CPCC07D417/12A61P35/02A61K31/506C07B2200/13C07D417/14
Inventor 罗摩克里希纳·帕拉梅什瓦尔·巴特吉特兰德拉巴布·拉古纳达切蒂马里亚潘·卡利亚潘文卡塔·拉加文德拉查玉鲁·帕勒维贾巴斯卡·雷迪·雷加拉
Owner BIOCON LTD